Jain, U <br/><br/>
The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10.  [electronic resource] 

 -  British journal of pharmacology  Jan 2013 
 - 488-501 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5381 
<br/><br/><label>Standard No.: </label>10.1111/j.1476-5381.2012.02183.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Colitis--chemically induced<br/>Complement C3a--immunology<br/>Complement C5a--immunology<br/>Cytokines--immunology<br/>Dextran Sulfate<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Peptides, Cyclic--pharmacology<br/>Receptor, Anaphylatoxin C5a--antagonists & inhibitors